Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes

被引:24
作者
Beerens, E
Van Renterghem, L
Praet, M
Sturtewagen, Y
Weyers, S
Temmerman, M
Depypere, H
Claeys, P
Cuvelier, CA
机构
[1] Univ Ghent, Acad Dept Pathol, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Lab Bacteriol & Virol, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Dept Gynecol, B-9000 Ghent, Belgium
关键词
HPV DNA; genotypes; primary abnormal cervical cytology;
D O I
10.1111/j.1365-2303.2005.00266.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: In this study, we focus on the prevalence and occurrence of different anogenital human papillomavirus (HPV) genotypes in a first abnormal cervical screening test, and correlate HPV genotyping with the cytological diagnosis on thin-layer liquid-based preparations in routine gynaecological screening. Methods: Out of 780 abnormal smears, 513 tested positive for HPV. All 25 different HPV types were identified by Line Probe Assay. Results: The prevalence of high-risk HPV types increased from 72% in atypical squamous cell of undetermined significance to 94.5% in high-grade intra-epithelial lesion (HSIL). Co-infection with multiple HPV types was predominantly found in HSIL (35.8%). In the HSIL group the most common HPV types were 16, 52, 51 and 31; type 18 was rarely present. Conclusion: The role of types 31, 51 and 52 should be considered in future studies on vaccine development.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 32 条
  • [21] Role of HPV DNA testing in predicting cervical intraepithelial lesions: Comparison of HC HPV and ISH HPV
    Qureshi, MN
    Rudelli, RD
    Tubbs, RR
    Biscotti, CV
    Layfield, LJ
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2003, 29 (03) : 149 - 155
  • [22] Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485
  • [23] Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by hybrid capture II and polymerase chain reaction
    Riethmuller, D
    Gay, C
    Bertrand, X
    Bettinger, D
    Schaal, JP
    Carbillet, JP
    Lassabe, C
    Arveux, P
    Seilles, E
    Mougin, C
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (03) : 157 - 164
  • [24] Cervical cytological screening and human papillomavirus DNA testing in flanders
    Sahebali, S
    Depuydt, CE
    Segers, K
    Vereecken, AJ
    Bogers, JJ
    [J]. ACTA CLINICA BELGICA, 2003, 58 (04) : 211 - 219
  • [25] The 2001 Bethesda System - Terminology for reporting results of cervical cytology
    Solomon, D
    Davey, D
    Kurman, R
    Moriary, A
    O'Connor, D
    Prey, M
    Raab, S
    Sherman, M
    Wilbur, D
    Wright, T
    Young, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (16): : 2114 - 2119
  • [26] Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt
  • [27] 12::AID-PATH431&gt
  • [28] 3.0.CO
  • [29] 2-F
  • [30] Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students
    Winer, RL
    Lee, SK
    Hughes, JP
    Adam, DE
    Kiviat, NB
    Koutsky, LA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (03) : 218 - 226